Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists

Notable Labs, a medtech startup cofounded by former hedge fund manager Matthew De Silva after his father developed brain cancer, has closed a $10 million Series A round. The funding will be used to support clinical trials for the development of a diagnostic for people with blood cancers, starting with leukemia.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More